Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1978 1
1980 5
1981 1
1982 1
1983 3
1984 2
1985 1
1987 1
1988 2
1989 2
1990 4
1991 3
1992 4
1993 4
1994 4
1995 2
1996 2
1997 6
1998 3
1999 7
2000 3
2001 4
2002 6
2003 5
2004 7
2005 7
2006 9
2007 7
2008 2
2009 1
2010 2
2011 7
2012 9
2013 6
2014 4
2015 6
2016 7
2017 9
2018 9
2019 8
2020 9
2021 10
2022 11
2023 17
2024 13
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. Among authors: brooks da. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.
Shcherbinin S, Evans CD, Lu M, Andersen SW, Pontecorvo MJ, Willis BA, Gueorguieva I, Hauck PM, Brooks DA, Mintun MA, Sims JR. Shcherbinin S, et al. Among authors: brooks da. JAMA Neurol. 2022 Oct 1;79(10):1015-1024. doi: 10.1001/jamaneurol.2022.2793. JAMA Neurol. 2022. PMID: 36094645 Free PMC article. Clinical Trial.
Altered endosomal-lysosomal biogenesis in melanoma.
Lam GT, Sorvina A, Martini C, Prabhakaran S, Ung BS, Lazniewska J, Moore CR, Beck AR, Hopkins AM, Johnson IRD, Caruso MC, Hickey SM, Brooks RD, Jackett L, Karageorgos L, Foster-Smith EJ, Malone V, Klebe S, O'Leary JJ, Brooks DA, Logan JM. Lam GT, et al. Among authors: brooks da. Neoplasia. 2023 Sep;43:100924. doi: 10.1016/j.neo.2023.100924. Epub 2023 Aug 9. Neoplasia. 2023. PMID: 37562257 Free PMC article.
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials.
Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, Sparks J, Andersen S, Lauzon S, Nery ESM, Battioui C, Engle SE, Biffi A, Svaldi D, Salloway S, Greenberg SM, Sperling RA, Mintun M, Brooks DA, Sims JR. Zimmer JA, et al. Among authors: brooks da. JAMA Neurol. 2025 Mar 10:e250065. doi: 10.1001/jamaneurol.2025.0065. Online ahead of print. JAMA Neurol. 2025. PMID: 40063015 Free PMC article.
Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction.
Wang H, Serap Monkul Nery E, Ardayfio P, Khanna R, Otero Svaldi D, Gueorguieva I, Shcherbinin S, Andersen SW, Hauck PM, Engle SE, Brooks DA, Collins EC, Fox NC, Greenberg SM, Salloway S, Mintun MA, Sims JR. Wang H, et al. Among authors: brooks da. Alzheimers Dement. 2025 Apr;21(4):e70062. doi: 10.1002/alz.70062. Alzheimers Dement. 2025. PMID: 40172303 Free PMC article. Clinical Trial.
The endosomal network.
Brooks DA. Brooks DA. Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S9-17. doi: 10.5414/cpp47009. Int J Clin Pharmacol Ther. 2009. PMID: 20040307 Review.
Lipid uptake in chronic lymphocytic leukemia.
Thurgood LA, Best OG, Rowland A, Lower KM, Brooks DA, Kuss BJ. Thurgood LA, et al. Among authors: brooks da. Exp Hematol. 2022 Feb;106:58-67. doi: 10.1016/j.exphem.2021.12.193. Epub 2021 Dec 8. Exp Hematol. 2022. PMID: 34896245 Free article.
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
Tang J, Lam GT, Brooks RD, Miles M, Useckaite Z, Johnson IR, Ung BS, Martini C, Karageorgos L, Hickey SM, Selemidis S, Hopkins AM, Rowland A, Vather R, O'Leary JJ, Brooks DA, Caruso MC, Logan JM. Tang J, et al. Among authors: brooks da. Cancer Lett. 2024 Mar 31;585:216639. doi: 10.1016/j.canlet.2024.216639. Epub 2024 Jan 28. Cancer Lett. 2024. PMID: 38290660 Free article. Review.
Laronidase treatment of mucopolysaccharidosis I.
Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA. Wraith EJ, et al. Among authors: brooks da. BioDrugs. 2005;19(1):1-7. doi: 10.2165/00063030-200519010-00001. BioDrugs. 2005. PMID: 15691212 Review.
222 results